Infants’ Swine Flu Vaccine Is Recalled as Less Potent

Posted by ObeMike Wednesday, December 16, 2009 0 comments

source: NYTimes

Nearly a million doses of swine flu vaccine for infants may have been slightly less potent than required but should work anyway, federal officials said Tuesday in announcing a recall of the shots.

The maker of the vaccine, Sanofi-Aventis, voluntarily recalled 800,000 doses of low-dose, thimerosal-free vaccine in pre-filled syringes intended for infants ages 6 months to 35 months, the Centres for Disease Control and Prevention said.

Since most of the vaccine was released a month ago, it presumably has already been used, but the recall is intended to alert doctors to return any supplies they have left.

Dr. Anne Schuchat, director of the National Centre for Immunization and Respiratory Diseases, said the vaccine was fully potent at release but dropped by about 12 percent in follow-up tests.


Nonetheless, Dr. Schuchat said, “we think children who got the vaccine are fully protected, assuming they got the two shots we recommend for that age.”

“We don’t think parents need to contact their doctors,” she continued.

The vaccine was the only thimerosal-free version licensed for children under 2 years old. Thimerosal is a mercury-based preservative that federal health officials consider harmless, but some parents are afraid of it because anti-vaccine activists blame it for autism and other ills.

Low doses in multidose vials, which contain thimerosal to kill any bacteria or fungus accidentally introduced by needles piercing the rubber stopper, remain available for infants.

Two-year-olds can use the nasal spray vaccine, which contains no thimerosal.

About 95 million doses in various forms are now available, Dr. Schuchat said.

| edit post

Norway - 79 People Lose Taste and Smell After H1N1 Vaccine

Posted by ObeMike Tuesday, December 15, 2009 4 comments

source: preventdisease.com

79 have lost their ability to taste or smell after taking the H1N1 swine flu vaccine in Norway.
 

Silje Marie Vatvik lost both taste and smell after taking the vaccine against swine flu. She has been sick for several weeks.
 
"People do not understand what it means to have taste and odor. I do not taste the food and can therefore do not want to swallow it. It inhibits me socially because I can attend dinner functions, " says Silje Marie Vatvik.
 
The 30-year-old who lives in Longyearbyen, was one of the first to receive the vaccine against swine flu. She worked in the department responsible for preparedness initiatives at the airport and was expected by her employer to be vaccined the same day first vaccines arrived on October 21.
 

"Had I not been expected to take the vaccine, I would have at least had the option, and the first thing I asked about were the side effects,", said Vatvik.
 
Vatvik was not prepared for what was to come after the vaccination, losing both her ability to taste and smell. She has not recovered these senses since taking the vaccine. The hospital administered many tests but the 30-year old has not responded to any of them.
 
"They kept all options open since it could have been a coincidence and nothing to do with the vaccine. But it was ultimately the one cause that remained," she says.

Vatvik is on sick leave indefinitely due to the illness. "I think about food all the time, have little energy and I'm irritable because I have low blood sugar," she says.
 
"There has been much talk about the vaccine not being tested, but it has been accepted in other countries before Norway. I know that foreign websites have been written about the loss of smell and taste associated with the vaccine, so it is strange that they were not more informed about it," said Vatvik.
 
When she went to the hospital, no one had heard of any similar cases. Now 79 people are suffering the same side effects notes the Norwegian Medicines Agency. They have no explanation for why some have lost their taste and smell after flu vaccine.
 
"It was unknown to us in advance that the loss of taste and sense of smell could be a side effect," said a spokesman from the Norwegian Medicines Agency, Steinar Madsen.
 
Madsen could not address why some patients suffer from the side effect. "We have no explanation for why it happens. We can not say for sure whether it has a relationship with the vaccine. There are other explanations, like that you get a viral infection while taking the vaccine," says Madsen.
 
When asked how long the patients it will take patients to recover, Madsen said, "I can not answer. I have talked to one patient who told me that she was well again after a couple of weeks."

| edit post

H1N1 Swine Flu Vaccine...more information....

Posted by wicked blu Monday, December 14, 2009 0 comments

Source: www.preventdisease.com 

Science dictates that only a randomized double-blind, placebo-controlled study can generate unbiased results in any clinical trial. In the history of vaccine development, no such study has ever been performed. It is only unscientific opinions and pharmaceutical propaganda which have propelled the mythological validity, safety and effectiveness of vaccines. Dozens of controlled studies have scientifically verified the immunotoxicty, neurotoxicity and sterility of common vaccine ingredients which destroy human health, yet they are all ignored by conventional medicine.

There should be a public outcry and challenge to every public health official, medical specialist or scientist (from any country) who justifies the inoculation of their population without providing the evidence of safety and effectiveness of the respective H1N1 vaccine in their country.


The public should be demanding that their governments materialize at least one vaccine trial which is randomized, double-blind and placebo-controlled that can scientifically validate the assertions of public health officials.

Since the pharmacokinetic properties of vaccines are not studied, vaccine manufacturers cannot deny any of the toxic effects listed below. The reason they never analyze the absorption, distribution, metabolism or excretion of these ingredients is because it would eradicate the vaccine industry. However the individual effects of each ingredient and their toxic effects on cells are well documented.

Every Physician, Nurse or medical personnel who administers the H1N1 vaccine (or any vaccine) should be asking themselves why they are injecting the following ingredients into patients that have been scientifically proven to cause immunotoxicity, neurotoxicity, sterility and cancer: 

Novartis Focetria Adjuvanted H1N1
Influenza Vaccine Ingredients/Toxicity
Polysorbate 80: Sterilie Agent
Squalene: Neurotoxin
Thimerosal: Neurotoxin  

Novartis H1N1 Monovalent Influenza Vaccine Ingredients/Toxicity
Polymyxin: Neurotoxin
Neomycin: Immunotoxin
Thimerosal: Neurotoxin  

GlaxoSmithKline Arepanrix Adjuvanted
H1N1 Influenza Vaccine Ingredients/Toxicity
Formaldehyde : Carcinogen
Polysorbate 80: Sterilie Agent
Squalene: Neurotoxin
Thimerosal: Neurotoxin 

GlaxoSmithKline Pandemrix Adjuvanted
H1N1 Influenza Vaccine Ingredients/Toxicity
Octoxynol 10: Immunotoxin
Polysorbate 80: Sterilie Agent
Squalene: Neurotoxin
Thimerosal: Neurotoxin 

GlaxoSmithKline Fluarix 2009-2010
Formula Ingredients/Toxicity
Formaldehyde : Carcinogen
Octoxynol 10: Immunotoxin
Polysorbate 80: Sterilie Agent
Formaldehyde : Carcinogen
Polyethylene Glycol: Systemic Toxin
Thimerosal: Neurotoxin 

MedImmune H1N1 Vaccine Ingredients/Toxicity
Gentamicin Sulfate: Nephrotoxic
Formaldehyde : Carcinogen
Polysorbate 80: Sterilie Agent
Thimerosal: Neurotoxin 

CSL PANVAX H1N1 Vaccine Ingredients/Toxicity
Beta-Propiolactone: Carcinogen
Neomycin: Immunotoxin
Sodium Taurodeoxycholate: Carcinogen/Immunotoxin
Polymyxin: Neurotoxin
Thimerosal: Neurotoxin 

CSL Afluria H1N1 Influenza Vaccine Ingredients/Toxicity
Neomycin Sulfate: Immunotoxin
Polymyxin B: Neurotoxin
Sodium Taurodeoxycholate: Carcinogen/Immunotoxin
Thimerosal: Neurotoxin


| edit post

Tamiflu anti-viral drug revealed as complete hoax; Roche studies based on scientific fraud

Posted by wicked blu 0 comments

Source: www.naturalnews.com 

When it comes to selling chemicals that claim to treat H1N1 swine flu, the pharmaceutical industry's options are limited to two: Vaccines and anti-virals. The most popular anti-viral, by far, is Tamiflu, a drug that's actually derived from a Traditional Chinese Medicine herb called star anise.

But Tamiflu is no herb. It's a potentially fatal concentration of isolated chemical components that have essentially been bio-pirated from Chinese medicine. And when you isolate and concentrate specific chemicals in these herbs, you lose the value (and safety) of full-spectrum herbal medicine.

That didn't stop Tamiflu's maker, Roche, from trying to find a multi-billion-dollar market for its drug. In order to tap into that market, however, Roche needed to drum up some evidence that Tamiflu was both safe and effective. 

Roche engages in science fraud

Admissions by people who catch the flu and then get put on Tamiflu.Roche claims there are ten studies providing Tamiflu is both safe and effective. According to the company, Tamiflu has all sorts of benefits, including a 61% reduction in hospital
The problem with these claims is that they aren't true. They were simply invented by Roche.

A groundbreaking article recently published in the British Medical Journal accuses Roche of misleading governments and physicians over the benefits of Tamiflu. Out of the ten studies cited by Roche, it turns out, only two were ever published in science journals. And where is the original data from those two studies? Lost. 

The data has disappeared. Files were discarded. The researcher of one study says he never even saw the data. Roche took care of all that, he explains.

So the Cochrane Collaboration, tasked with reviewing the data behind Tamiflu, decided to investigate. After repeated requests to Roche for the original study data, they remained stonewalled. The only complete data set they received was from an unpublished study of 1,447 adults which showed that Tamiflu was no better than placebo. Data from the studies that claimed Tamiflu was effective was apparently lost forever.

As The Atlantic reports, that's when former employees of Adis International (essentially a Big Pharma P.R. company) shocked the medical world by announcing they had been hired to ghost-write the studies for Roche.

It gets even better: These researchers were told what to write by Roche! 

As one of these ghostwriters told the British Medical Journal:

"The Tamiflu accounts had a list of key messages that you had to get in. It was run by the [Roche] marketing department and you were answerable to them. In the introduction ...I had to say what a big problem influenza is. I'd also have to come to the conclusion that Tamiflu was the answer."

In other words, the Roche marketing department ran the science and told researchers what conclusions to draw from the clinical trials. Researchers hired to conduct the science were controlled by the marketing puppeteers. No matter what they found in the science, they had already been directed to reach to conclusion that "Tamiflu was the answer."

| edit post

64 People Die in Japan After Getting Swine Flu Jab

Posted by ObeMike Thursday, December 10, 2009 0 comments

source: theflucase 

A total of 64 people have died in Japan as of December 8th after receiving the swine flu shot, according to a report in the newspaper Mainichi. 


One teenage boy died immediately after taking the shot. 


Another man was found dead in his home four days after he received a swine flu jab.
He complained of stomach ache and vomitted and died later at home on his own.
His doctor stated his death was not linked with H1N1 flu shot and that the side effect of the shot was only a stomach ache. 


In addtion, there have been many reports of deaths related to Tamiflu in Japan, including young people falling to their deaths from their appartment after taking Tamiflu, violent and irrational actions and hallucinations. 



But while the Japanese corporate media appears to downplay the side effects of the swine flu jab and of Tamiflu, it exaggerates the threat of the mild swine flu. 


Accoording to Sankei news on November 27th, more than 100,000 people have been infected with swine flu in Japan. The total number of deaths caused by the siwne flu is over 100 people, it is maintained. 


The Japanse government completed the first phase of its mass vaccination programme in the middle of November, after giving 450,000 people the jab. 


Children and pregnant women were given the priority groups vaccinated using a swine flu vaccine made in Japan.

| edit post

Swine Flu Vaccine Manufactures Glaxo Smith Kline's Directors List.

Posted by ObeMike Wednesday, December 9, 2009 0 comments

source: tpuc.org

For those of you who are interested in the company behind the swine flu vaccine have a look at Glaxo Smith Kline’s directors list. It makes fascinating reading and you can cross reference a few of the directors regarding some interesting events and positions they hold. If you can add anymore information to this please contact info@tpuc.org

Even though Liam Donaldson is not on the directors list we feel you need to have some information regarding this man.

Sir Liam Donaldson – Chief Medical Officer (CMO) Department of Health

This man approved Mercury & Squalene to be in the injection to be given to pregnant women & children, he is also the chair of the WHO (World Health Organization) Patient Safety Secretariat.

Now on to the directors.

James Murdoch - Son of Rupert Murdoch
CEO of News International Ltd who is ideally placed to control propaganda regarding the swine Flu & the vaccine. James Murdoch was appointed to the board of directors of Glaxo SmithKline PLC 20th May 2009.

Sir Roy Anderson (Scientist) – sits on the governments SAGE committee and is a director of Glaxo SmithKline the purveyors of the swine flu vaccine to H.M Government with a nice little pay packet of £116k a year, at least a quarter of what he receives from his shares ….hold on surely this amounts to a ‘conflict of interests’.

SAGE (Scientific Advisory Group for Emergencies) recommends that everyone should have the yet untested, unsafe and toxic Swine Flu Vaccine.

See original article and directors list here

| edit post

British Medical Journal Questions Efficacy of Tamiflu For Swine Flu — or Any Flu

Posted by ObeMike 0 comments

source: L.A.Times



A major controversy about the efficacy of the antiviral agent Tamiflu in treating influenza has erupted in the online version of BMJ, formerly known as the British Medical Journal. A team from the prestigious Cochrane Review says that its analysis of published data about clinical trials of the drug, known generically as oseltamivir, shows that the drug is able to reduce the course of an influenza infection by a day but that they are unable to conclude that the drug is effective at reducing complications and hospitalizations caused by flu because they do not have access to key data from eight clinical trials sponsored by the drug's manufacturer, Roche Laboratories Inc. In a commentary accompanying the report, BMJ editor Fiona Godlee said, "Governments around the world have spent billions of pounds on a drug that the scientific community now finds itself unable to judge."

In a response, Roche officials said that the data from the eight trials simply duplicated the results from published trials and did not provide enough new information to justify publication. The company also said that all of the data were submitted to the Food and Drug Administration and other regulatory agencies when the company sought approval to market the drug and that those agencies found it convincing. Roche also said it would post the eight disputed trials on a password-protected website so that researchers would have access to it — although that has not occurred yet.

Although the controversy involves trials of the drug against seasonal influenza, the debate has particular significance now because Tamiflu is the primary tool used in combating pandemic H1N1 influenza in the face of poor availability of the swine flu vaccine. In response to the new findings, both the World Heatlh Organizaton and the Centres for Disease Control and Prevention said they would continue to stand by their guidelines for use of the drug, arguing that it is not a good tool for prophylaxis against the swine flu virus but that it does provide benefit in reducing complications. 

The Cochrane Review is a nonprofit British organizaton that specializes in independently reviewing published trials on drug efficacy to determine whether the medications are effective. In a 2005 review of Tamiflu and a 2008 update, a group headed by Tom Jefferson of the Cochrane Collaboration's Acute Respiratory Infections Group in Rome concluded that the drug was effective in reducing influenza complications. But a letter from Japanese pediatrician Keiji Hayashi this summer questioned its conclusion, arguing that the team had not actually seen much of the data on which they were basing its conclusion. Hayashi was concerned about the side effects of the drug, which include insomnia, nausea, bad dreams, abdominal pain, headache and a rare neuropsychiatric disease that caused some users to attempt to harm themselves. Such side effects might be tolerated if the drug was effective, but not otherwise. Hayashi was particularly concerned because Japan consumes more than 60% of the world production of the drug.

Under Cochrane rules, the team had six months to respond to Hayashi.

Jefferson attempted to obtain data from the trials, but the situation took a strange turn when the request was made through England's Channel 4 News, which was also investigating the efficacy of Tamiflu. Eventually, Roche agreed to provide the data, providing Jefferson would sign a confidentiality agreement preventing its publication. He refused, and negotiations reached an impasse. Meanwhile, the six-month deadline was nearing its expiration, and Jefferson's team decided to publish its findings without considering the data from the eight studies. And without those studies, they could not reach any conclusions about the effectiveness of the drug.

Roche also provided BMJ with some data about observational studies of Tamiflu, which the group forwarded to Dr. Nick Freemantle and Dr. Melanie Calvert of the University of Birmingham. Reviewing the data, they concluded that "oseltamivir may reduce the risk of pneumonia in otherwise healthy people who contract flu. However, the absolute benefit is small, and side effects and safety should also be considered."

Jefferson's team and BMJ had other concerns about the clinical studies, including original documents that cited Roche employees whose names did not appear on the final papers and the use of professional writers to help produce published papers. Roche made a point-by-point response to their concerns in an online statement. The company also noted that it was standard industry practice 10 years ago, when the studies appeared, not to publish all results from clinical trials and to employ professional writers whose names did not appear on published reports. The company said that its policies have since changed and that it now publishes all new data online and acknowledges all contributions to written reports.

The final conclusions from the brouhaha: It probably doesn't hurt to treat patients with severe flu complications with Tamiflu, and it may help. But the drug should not be used in an effort to prevent infection among people who have been exposed to the virus or in those who have only very mild infections.

| edit post

Welcome


Thank you for visiting 'Do Not Inject Me'

The purpose of this site is to bring to your attention the dangers of all vaccines, pharmaceutical drugs and some of the severe effects they can have on you as a human being.

Along the way we hope to provide you with health articles regarding alternative and natural remedies, and that you find the information presented here a great resource in empowering you to become a more active and healthier being.


Say No!

Say No!

Natural News

Loading...

Dr. Mercola

Loading...

Vac Truth

Loading...

Christina England

Loading...

Followers